WASHINGTON (MedPage Today) -- Diabetic patients who reached aggressive lipid-lowering targets saw nearly identical vascular benefits whether on high-dose statins alone or with ezetimibe (Zetia), researchers found.
Aggressive Lipid Lowering Controls Atherosclerosis EffectsCourtesy MedPage Today Infectious Disease Thu, 12/04/2008 - 09:02
WASHINGTON (MedPage Today) -- Diabetic patients who reached aggressive lipid-lowering targets saw nearly identical vascular benefits whether on high-dose statins alone or with ezetimibe (Zetia), researchers found. More related itemsSurvey Report: Many Doctors Stand by Ezetimibe (Zetia)
ASMBS: Statin Use Lower after Gastric Bypass (CME/CE)
ESC: SEAS Data Answer Some Questions But Raise Other...
|
Popular by tags WeekMonth |
Post new comment